GEODE CAPITAL MANAGEMENT, LLC - COGNITION THERAPEUTICS INC ownership

COGNITION THERAPEUTICS INC's ticker is and the CUSIP is 19243B102. A total of 28 filers reported holding COGNITION THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of COGNITION THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$251,776
-22.0%
174,798
-1.0%
0.00%
Q2 2023$322,991
+33.1%
176,498
+44.0%
0.00%
Q1 2023$242,744
+94352.9%
122,5980.0%0.00%
Q4 2022$257
-99.8%
122,598
+52.5%
0.00%
Q3 2022$152,000
+375.0%
80,409
+430.0%
0.00%
Q2 2022$32,000
-13.5%
15,171
+10.5%
0.00%
Q1 2022$37,00013,7260.00%
Other shareholders
COGNITION THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 240,080$660,0000.43%
P.A.W. CAPITAL CORP 120,000$330,0000.34%
Worth Venture Partners, LLC 175,366$473,0000.22%
AMERICAN FINANCIAL GROUP INC 205,000$564,0000.17%
APOGEM CAPITAL LLC 17,667$49,0000.03%
Diligent Investors, LLC 30,520$84,0000.02%
Nantahala Capital Management 196,402$540,0000.02%
Voss Capital, LLC 26,439$71,0000.02%
B. Riley Financial, Inc. 30,904$85,0000.02%
Rock Creek Group, LP 26,439$71,0000.01%
View complete list of COGNITION THERAPEUTICS INC shareholders